• Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$2.17
▼ -0.01 (-0.46%)
Get New Vapotherm Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VAPO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VAPO

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Vapotherm in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $2.17.

This chart shows the closing price for VAPO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Vapotherm. This rating has held steady since July 2023, when it changed from a Reduce consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
6/17/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/15/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/14/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/13/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/11/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/9/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/8/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/8/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/4/2022BTIG ResearchDowngradeBuy ➝ Neutral
8/4/2022William BlairDowngradeOutperform ➝ Market Perform
8/4/2022Piper SandlerLower TargetUnderweight$20.00 ➝ $16.00
6/24/2022BTIG ResearchLower TargetBuy$72.00 ➝ $56.00
5/26/2022Piper SandlerLower TargetUnderweight$40.00 ➝ $20.00
5/6/2022Canaccord Genuity GroupDowngradeBuy ➝ Hold$96.00 ➝ $40.00
5/5/2022Piper SandlerLower Target$64.00 ➝ $40.00
4/18/2022BTIG ResearchLower Target$296.00 ➝ $80.00
4/13/2022Canaccord Genuity GroupLower TargetBuy$168.00 ➝ $96.00
4/7/2022Piper SandlerDowngradeOverweight ➝ Underweight$184.00 ➝ $64.00
2/25/2022Canaccord Genuity GroupLower Target$280.00 ➝ $168.00
1/13/2022Canaccord Genuity GroupLower TargetBuy ➝ Buy$328.00 ➝ $280.00
9/27/2021BTIG ResearchReiterated RatingBuy$360.00
2/25/2021Piper SandlerLower TargetOverweight$312.00 ➝ $288.00
1/15/2021Piper SandlerBoost TargetOverweight$288.00 ➝ $312.00
12/17/2020Piper SandlerInitiated CoverageOverweight$288.00
8/4/2020BTIG ResearchReiterated RatingBuy$424.00
7/13/2020BTIG ResearchBoost Target$256.00 ➝ $424.00
5/26/2020BTIG ResearchReiterated RatingBuy$256.00
5/5/2020BTIG ResearchReiterated RatingBuy$256.00
3/5/2020William BlairReiterated RatingOutperform
3/5/2020BTIG ResearchReiterated RatingBuy$184.00
(Data available from 12/8/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/12/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/11/2024
  • 1 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/11/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/10/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/9/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/9/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/8/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/8/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Vapotherm logo
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.
Read More

Today's Range

Now: $2.17
Low: $2.16
High: $2.17

50 Day Range

MA: $2.16
Low: $2.13
High: $2.18

52 Week Range

Now: $2.17
Low: $0.70
High: $3.44

Volume

51,500 shs

Average Volume

N/A

Market Capitalization

$13.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Vapotherm?

The following equities research analysts have issued research reports on Vapotherm in the last year:
View the latest analyst ratings for VAPO.

What is the current price target for Vapotherm?

0 Wall Street analysts have set twelve-month price targets for Vapotherm in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Vapotherm in the next year.
View the latest price targets for VAPO.

What is the current consensus analyst rating for Vapotherm?

Vapotherm currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for VAPO.

What other companies compete with Vapotherm?

How do I contact Vapotherm's investor relations team?

Vapotherm's physical mailing address is 100 DOMAIN DRIVE, EXETER NH, 03833. The company's listed phone number is (866) 410-9986 and its investor relations email address is [email protected]. The official website for Vapotherm is www.vapotherm.com. Learn More about contacing Vapotherm investor relations.